Article Type
Changed
Fri, 02/08/2019 - 04:00

 

A plasma proteomic study has identified new biomarkers for Alzheimer’s disease pathology in cognitively unimpaired individuals. Also today, biomarkers predict VTE risk with menopausal oral hormone therapy, there is a cloud of inconsistency hanging over cannabis data, and compounded pain creams are no better than placebo for chronic localized pain.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

 

Publications
Sections

 

A plasma proteomic study has identified new biomarkers for Alzheimer’s disease pathology in cognitively unimpaired individuals. Also today, biomarkers predict VTE risk with menopausal oral hormone therapy, there is a cloud of inconsistency hanging over cannabis data, and compounded pain creams are no better than placebo for chronic localized pain.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

 

 

A plasma proteomic study has identified new biomarkers for Alzheimer’s disease pathology in cognitively unimpaired individuals. Also today, biomarkers predict VTE risk with menopausal oral hormone therapy, there is a cloud of inconsistency hanging over cannabis data, and compounded pain creams are no better than placebo for chronic localized pain.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

 

Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica